Melbourne, FL, United States
Pacifico National, Inc. dba AmEx Pharmacy recalls
2 recalls recorded since 2018, most recently on 30 August 2019. None are listed as ongoing. Status and classification are as published by the FDA.
Recalls2
Ongoing (FDA)0
Terminated or completed2
Class I (FDA)0
Terminated Class II Drugs
- Recall started
- 30 August 2019
- Terminated
- 8 October 2020
- Reason
- Lack of assurance of sterility.
- Distribution
- Continental U.S. and Puerto Rico
- Initiated
- Voluntary: Firm initiated
- Recall numbers
- D-1849-2019, D-1850-2019
- Bevacizumab, 2.5 mg/0.1 mL, Norm-Ject Syringe Intravitreal Injection, Single use only, Rx only, Repackaged by AmEx Pharmacy 1515 Elizabeth St. Suite J Melbourne, FL 32901
- Bevacizumab, 1.25 mg/0.05 mL, 31G MJ Syringe Intravitreal Injection, Single use only, Rx only, Repackaged by AmEx Pharmacy 1515 Elizabeth St. Suite J Melbourne, FL 32901
Terminated Class II Drugs
- Recall started
- 19 April 2019
- Terminated
- 16 February 2021
- Reason
- Defective Delivery System: difficult to express
- Distribution
- Nationwide in the US
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-1271-2019
- BEVACIZUMAB 1.25 mg/0.05 mL 31G MJ syringe Intravitreal Injection. This biologic product was repackaged by AmEx Pharmacy 1515 Elizabeth St. Suite J Melbourne, FL 32901 Lot:190212AB BUD:5/13/2019, Repackaged on 2/12/2019
A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.